Cargando…
Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
BACKGROUND: The Coronavirus (COVID-19), (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) has been spreading worldwide since its first identification in China. It has been speculated that patients with comorbidities and elderly patients could be at high risk for the pandemic reasoned re...
Autores principales: | Gemcioglu, Emin, Davutoglu, Mehmet, Ozdemir, Ese Ece, Erden, Abdulsamet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228888/ https://www.ncbi.nlm.nih.gov/pubmed/32480326 http://dx.doi.org/10.1016/j.msard.2020.102196 |
Ejemplares similares
-
False positivity of Rose Bengal test in patients with COVID-19: case series, uncontrolled longitudinal study
por: Gemcioglu, Emin, et al.
Publicado: (2020) -
Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients
por: San, Ishak, et al.
Publicado: (2021) -
Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission
por: Gemcioglu, Emin, et al.
Publicado: (2021) -
Interferon Treatment of Multiple Sclerosis
por: Alajbegovic, Azra, et al.
Publicado: (2012) -
Could Heterozygous Beta Thalassemia Provide Protection Against Multiple Sclerosis?
por: Cikrikcioglu, Mehmet Ali, et al.
Publicado: (2016)